Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores-MedSci.cn

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Targher, G; Mantovani, A; Byrne, CD; Wang, XB; Yan, HD; Sun, QF; Pan, KH; Zheng, KI; Chen, YP; Eslam, M; George, J; Zheng, MH

Targher, G (corresponding author), Univ Verona, Dept Med Endocrinol & Metab, I-37126 Verona, Veneto, Italy.; Zheng, MH (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.

GUT, 2020; 69 (8): 1545

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

科室

工具

服务